ArticleInternal medicine (Tokyo, Japan)2018

Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.

Haruki Uojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.